How frequently should the pneumococcal vaccine be administered?

Pneumococcal Vaccination Frequency for Adults

For most healthy adults aged ≥65 years, you need only ONE dose of a pneumococcal conjugate vaccine (PCV20 or PCV21) in your lifetime—this is not a recurring shot. 1

Key Vaccination Schedules by Age and Risk Status

Healthy Adults ≥65 Years (No High-Risk Conditions)

• Single lifetime dose of PCV20, PCV21, or PCV15 1
• If PCV15 is used, follow with one dose of PPSV23 at least 1 year later
• No routine revaccination needed after completing the series

Adults Aged 50-64 Years Without Risk Conditions

• Single dose of PCV for all adults ≥50 years who have never received pneumococcal vaccine 2
• This represents the most recent 2024 expansion of recommendations

Adults 19-64 Years With Chronic Medical Conditions

(Diabetes, COPD, heart disease, liver disease, smoking, alcoholism)

• Single dose of PCV20, PCV21, or PCV15 1
• If PCV15 used: add PPSV23 ≥1 year later
• Review recommendations again at age 65 to determine if additional vaccination needed

Adults With Immunocompromising Conditions

(HIV, cancer, organ transplant, immunosuppressive therapy, chronic kidney disease, asplenia, cochlear implants, CSF leaks)

This is the ONLY group that may need multiple doses:

• Initial: PCV20, PCV21, or PCV15 1
• If PCV15 used: PPSV23 follows after ≥8 weeks
• Second PPSV23 dose may be needed ≥5 years after the first PPSV23 (for immunocompromised patients aged 19-64 years only—not for cochlear implants or CSF leaks alone) 3
• Review at age 65 for potential additional dose

Critical Timing Intervals

When transitioning between vaccines or catching up:

• PCV to PPSV23: Minimum 8 weeks for immunocompromised; 1 year for others 1
• PPSV23 to PCV: Minimum 1 year interval 1
• Between PPSV23 doses: Minimum 5 years 1
• PCV13 to newer PCV (PCV20/PCV21): Minimum 1 year 1

Common Clinical Scenarios

Previously received only PPSV23:

• Give one dose of PCV20, PCV21, or PCV15 at least 1 year after last PPSV23 1
• Series is then complete (unless immunocompromised)

Previously received only PCV13:

• Give one dose of PCV20, PCV21, or PPSV23 at least 1 year later 1
• If PPSV23 chosen for immunocompromised: may need second PPSV23 ≥5 years later

Completed both PCV13 and PPSV23 at age ≥65:

• Shared decision-making for optional PCV20 or PCV21 if ≥5 years since last dose 1
• Not routinely required; discuss individual risk/benefit

Important Caveats

The "5-year revaccination" concept is outdated. Older guidelines recommended PPSV23 revaccination every 5 years, but current recommendations focus on completing a one-time series with newer conjugate vaccines that provide more durable immunity 1. The 5-year interval now applies only to:

• Spacing between PPSV23 doses when multiple doses are indicated
• Minimum interval before adding newer PCV vaccines to prior vaccination history

Hematopoietic stem cell transplant recipients are the exception, requiring a special 4-dose PCV20 series starting 3-6 months post-transplant 3.

The newer conjugate vaccines (PCV15, PCV20, PCV21) provide superior immune responses compared to PPSV23 alone, which is why current guidelines emphasize completing the series with these vaccines rather than repeated PPSV23 doses 3.